Gujarat Themis Biosyn (NSE:GUJTHEM) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:GUJTHEM Gujarat Themis Biosyn Ltd NSE:GUJTHEM
66 GF Score
Price ₹371.30
GF Value ₹351.48
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Gujarat Themis Biosyn FFO per Share?

FFO per Share only applies to REITs.

NSE:GUJTHEM
66GF Score
Gujarat Themis Biosyn Ltd NSE:GUJTHEM
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Gujarat Themis Biosyn (NSE:GUJTHEM) Overvalued in 2026?

Based on GuruFocus' analysis, Gujarat Themis Biosyn stock appears to be overvalued. The current stock price of ₹371.30 is trading 5.6% above its estimated GF Value™ of ₹351.48. GuruFocus considers Gujarat Themis Biosyn to be Fairly Valued.

Key valuation signals for NSE:GUJTHEM:

  • FFO per Share:
  • GF Value™: ₹351.48 vs. price of ₹371.30 (5.6% above fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the NSE:GUJTHEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gujarat Themis Biosyn Business Description

Other Exchanges 506879:India
Address S.V Road, Themis House, 11/12 Udyog Nagar, Goregaon (West), Mumbai, MH, IND, 400104
Gujarat Themis Biosyn Ltd is engaged in manufacturing, exporting, and selling of bulk drugs on a job-work basis. The company operates in one segment which is pharmaceuticals. Its products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin.
66GF Score

Get the complete analysis for NSE:GUJTHEM

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹371.30
Price
₹351.48
GF Value